Rothschild & Co Asset Management US’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-84,047
| Closed | -$621K | – | 365 |
|
|
2018
Q4 | $621K | Buy |
84,047
+35,249
| +72% | +$260K | 0.01% | 363 |
|
|
2018
Q3 | $709K | Sell |
48,798
-594
| -1% | -$8.63K | 0.01% | 360 |
|
|
2018
Q2 | $986K | Buy |
49,392
+7,446
| +18% | +$149K | 0.01% | 356 |
|
|
2018
Q1 | $735K | Sell |
41,946
-4,343
| -9% | -$76.1K | 0.01% | 345 |
|
|
2017
Q4 | $1.14M | Sell |
46,289
-3,494
| -7% | -$86.1K | 0.01% | 335 |
|
|
2017
Q3 | $1.29M | Sell |
49,783
-1,086
| -2% | -$28K | 0.01% | 319 |
|
|
2017
Q2 | $1.38M | Sell |
50,869
-2,301
| -4% | -$62.4K | 0.02% | 357 |
|
|
2017
Q1 | $1.59M | Buy |
53,170
+14,493
| +37% | +$432K | 0.02% | 340 |
|
|
2016
Q4 | $1.05M | Buy |
+38,677
| New | +$1.05M | 0.01% | 385 |
|